Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Longjiu Cui"'
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-6 (2020)
Abstract Hepatocellular carcinoma (HCC) is the leading cause of tumor death in China with high mortality since its strong metastatic potential. Currently, treatment against advanced HCC is poorly efficient and thus screening new drugs to prevent the
Externí odkaz:
https://doaj.org/article/47126ac4d30b4a11a465c47014284501
Autor:
Xiuliang Cui, Lu Han, Longjiu Cui, Gongbo Fu, Erdong Liu, Duowei Wang, Bin Song, Yongxiang Zhang, Wenxia Zhou, Hongyang Wang, Jing Fu
Publikováno v:
Pharmacological research.
The heterogeneity of tumor immune microenvironment (TIME) plays important roles in the development and immunotherapy response of hepatocellular carcinoma (HCC). Using machine learning algorithms, we introduced the immune index (IMI), a prognostic mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85fe194f446242225ae30e39448a0861
https://pubmed.ncbi.nlm.nih.gov/36574578
https://pubmed.ncbi.nlm.nih.gov/36574578
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-6 (2020)
Scientific Reports
Scientific Reports
Hepatocellular carcinoma (HCC) is the leading cause of tumor death in China with high mortality since its strong metastatic potential. Currently, treatment against advanced HCC is poorly efficient and thus screening new drugs to prevent the HCC invas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e936afeb32113b147d06dc3da8625c
https://doaj.org/article/47126ac4d30b4a11a465c47014284501
https://doaj.org/article/47126ac4d30b4a11a465c47014284501
Autor:
Jun Chen, Xiao-Lu Lin, Cong Zhuangzhi, Yong-Jie Zhang, Rong-zheng Ran, Tan Weifeng, Hai Zhang, Guoqing Zhang, Fan Mingming, Longjiu Cui
Publikováno v:
Experimental Cell Research. 378:66-75
Liver cancer stem cells (CSCs) contribute to tumorigenesis, progression, drug resistance and recurrence of hepatocellular carcinoma (HCC). However, the underlying mechanism for the propagation of liver CSCs remains unclear. Herein, we observed low ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9984971a847182b2e58efb8e31576a43
https://doi.org/10.1016/j.yexcr.2019.03.007
https://doi.org/10.1016/j.yexcr.2019.03.007
Autor:
Longjiu Cui, Xiaoqing Jiang, Liang Zhao, Yuanzhuo Chen, Zhangjun Cheng, Jiehua Li, Weifeng Tan, Alex F. Chen
Publikováno v:
Translational Cancer Research. 7:68-78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79c862af1dd12efa21b87be6e220d0b
https://doi.org/10.21037/tcr.2018.01.04
https://doi.org/10.21037/tcr.2018.01.04
Publikováno v:
Cancer Biomarkers. 2016, Vol. 16 Issue 4, p507-512. 6p.
Autor:
Jun Chen, Rong-zheng Ran, Cong Zhuangzhi, Weifeng Tan, Fan Mingming, Xiao-Lu Lin, Yong-Jie Zhang, Guoqing Zhang, Longjiu Cui, Hai Zhang
Publikováno v:
Experimental Cell Research. 395:112183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74ad88b7945bbec975a6baef3f6741ba
https://doi.org/10.1016/j.yexcr.2020.112183
https://doi.org/10.1016/j.yexcr.2020.112183
Autor:
Xinwei Yang, Zhiquan Qiu, Rongzhen Ran, Wei‑Feng Tan, Xiaoqing Jiang, Xiangji Luo, Meng-Chao Wu, Longjiu Cui
Publikováno v:
Oncology Letters
There is not yet a consensus regarding a difference in prognosis for patients with hepatocellular carcinoma (HCC) with and without bile duct invasion (BDI). The present study aimed to clarify the prognostic importance of BDI on the short and long-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc77302de583e903c58581cf117c2c2
https://doi.org/10.3892/ol.2018.9108
https://doi.org/10.3892/ol.2018.9108
Autor:
Xinwei, Yang, Rongzhen, Ran, Jing, Du, Zhiquan, Qiu, Longjiu, Cui, Xiaoqing, Jiang, Mengchao, Wu, Weifeng, Tan
Publikováno v:
International journal of clinical and experimental pathology. 11(8)
There is not yet a consensus regarding prognosis of hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) versus without bile duct tumor thrombus. Chemokine (C-C motif) ligand 20 (CCL20) plays critical roles in the progress of many type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc7708a42cd9f81a173dccc40cc64846
https://pubmed.ncbi.nlm.nih.gov/31949786
https://pubmed.ncbi.nlm.nih.gov/31949786
Autor:
Junliang Deng, Xinwei Yang, Xiaoqing Jiang, Weifeng Tan, Guangwei Du, Longjiu Cui, Rong-zheng Ran, Jingquan He
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Hepatocellular carcinoma with bile duct tumor thrombus (BDTT) is a malignant disease. The most commonly used diagnosis methods for BDTT are MRCP/ERCP, ultrasonic diagnosis or CT scan. However, BDTT is often misdiagnosed as other bile duct diseases, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b783c38eada08ac4940942a66e4c41
https://pubmed.ncbi.nlm.nih.gov/29459779
https://pubmed.ncbi.nlm.nih.gov/29459779